seventy-six patients with labyrinthine diseases of vascular origin were treated in a 6-week double-blind comparative study with either 400 mg pentoxifylline ( 'trental ' ) or 75 mg cinnarizine 3-times daily .
C0030899
pentoxifylline
C0699487
trental